Electro-physiological Changes in the Central Nervous System by Visual Evoked Potential in Diabetic Patients.


Journal

Journal of Nepal Health Research Council
ISSN: 1999-6217
Titre abrégé: J Nepal Health Res Counc
Pays: Nepal
ID NLM: 101292936

Informations de publication

Date de publication:
20 Jul 2023
Historique:
received: 29 06 2022
accepted: 20 07 2023
medline: 26 7 2023
pubmed: 25 7 2023
entrez: 25 7 2023
Statut: epublish

Résumé

Increasing sedentary lifestyle in today's world has increased the prevalence of Diabetes Mellitus. Loss of vision due to diabetic retinopathy is a major public health burden. Visual evoked potential identifies the neuronal degenerative changes in chronic metabolic disorders specially Diabetes Mellitus. The study aimed at evaluating changes in visual evoked potential waves in diabetic patients. This is a cross sectional comparative study consisting of 90 participants, out of which 60 were diabetic patients and 30 were non-diabetic control group. Among diabetic patients, 30 were without retinopathy, 10 with mild non-proliferative retinopathy, 10 with moderate non-proliferative retinopathy and 10 with severe non-proliferative retinopathy. Visually evoked potential latencies and amplitudes were compared among diabetic patients and the control group and also among individuals with different grades of retinopathy. Delay in P100 latency and decrease in its amplitude were statistically significant in diabetic patients. The changes in P100 latency, P100 amplitude and N75 latency were also significant in different grades of retinopathy. There are statistically significant changes in visually evoked potential in diabetes patients. Visual evoked potential is a useful, non-invasive investigation which can establish the central nervous system neuropathy in diabetes at an early stage of the disease. So Diabetic retinopathy can be prevented due to early detection of neuropathy by visual evoked potential test Keywords: Diabetes mellitus; diabetic retinopathy; visual evoked potential.

Sections du résumé

BACKGROUND BACKGROUND
Increasing sedentary lifestyle in today's world has increased the prevalence of Diabetes Mellitus. Loss of vision due to diabetic retinopathy is a major public health burden. Visual evoked potential identifies the neuronal degenerative changes in chronic metabolic disorders specially Diabetes Mellitus. The study aimed at evaluating changes in visual evoked potential waves in diabetic patients.
METHODS METHODS
This is a cross sectional comparative study consisting of 90 participants, out of which 60 were diabetic patients and 30 were non-diabetic control group. Among diabetic patients, 30 were without retinopathy, 10 with mild non-proliferative retinopathy, 10 with moderate non-proliferative retinopathy and 10 with severe non-proliferative retinopathy. Visually evoked potential latencies and amplitudes were compared among diabetic patients and the control group and also among individuals with different grades of retinopathy.
RESULTS RESULTS
Delay in P100 latency and decrease in its amplitude were statistically significant in diabetic patients. The changes in P100 latency, P100 amplitude and N75 latency were also significant in different grades of retinopathy.
CONCLUSIONS CONCLUSIONS
There are statistically significant changes in visually evoked potential in diabetes patients. Visual evoked potential is a useful, non-invasive investigation which can establish the central nervous system neuropathy in diabetes at an early stage of the disease. So Diabetic retinopathy can be prevented due to early detection of neuropathy by visual evoked potential test Keywords: Diabetes mellitus; diabetic retinopathy; visual evoked potential.

Identifiants

pubmed: 37489682
doi: 10.33314/jnhrc.v20i4.4334
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

947-951

Auteurs

Neha Malla (N)

Department of Clinical Physiology, Maharajgunj Medical Campus, Institute of Medicine.

Narayan B Mahotra (NB)

Department of Clinical Physiology, Maharajgunj Medical Campus, Institute of Medicine.

Lava Shrestha (L)

Department of Clinical Physiology, Maharajgunj Medical Campus, Institute of Medicine.

Sajun Narayan Joshi (SN)

B.P Koirala Lions Center for Opthalmic Studies, Institute of Medicine.

Sanyukta Gurung (S)

Department of Clinical Physiology, Maharajgunj Medical Campus, Institute of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH